These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 9274893)

  • 21. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis.
    Limaye AP; Bakthavatsalam R; Kim HW; Randolph SE; Halldorson JB; Healey PJ; Kuhr CS; Levy AE; Perkins JD; Reyes JD; Boeckh M
    Transplantation; 2006 Jun; 81(12):1645-52. PubMed ID: 16794529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.
    Mengelle C; Rostaing L; Weclawiak H; Rossignol C; Kamar N; Izopet J
    J Med Virol; 2015 May; 87(5):836-44. PubMed ID: 25655981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of pre-emptive therapy for cytomegalovirus after liver transplantation.
    Müller V; Perrakis A; Meyer J; Förtsch T; Korn K; Croner RS; Yedibela S; Hohenberger W; Schellerer VS
    Transplant Proc; 2012 Jun; 44(5):1357-61. PubMed ID: 22664015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
    Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
    Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
    Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
    Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
    Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?
    Kim JM; Kim SJ; Joh JW; Kwon CH; Song S; Shin M; Moon JI; Kim GS; Hong SH; Lee SK
    Liver Transpl; 2011 Apr; 17(4):446-55. PubMed ID: 21445928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
    Mabilangan C; Preiksaitis J; Cervera C;
    Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
    Santos CA; Brennan DC; Yusen RD; Olsen MA
    Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
    Linares L; Sanclemente G; Cervera C; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Marcos MA; Antón A; Pumarola T; Moreno A
    Transplant Proc; 2011; 43(6):2145-8. PubMed ID: 21839217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.
    Snydman DR
    Transpl Infect Dis; 2001; 3 Suppl 2():6-13. PubMed ID: 11926753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
    Rosen HR; Corless CL; Rabkin J; Chou S
    Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
    Mabilangan C; Preiksaitis JK; Cervera C;
    Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
    Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV
    Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis.
    Limaye AP; Bakthavatsalam R; Kim HW; Kuhr CS; Halldorson JB; Healey PJ; Boeckh M
    Transplantation; 2004 Nov; 78(9):1390-6. PubMed ID: 15548980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Werner BG; Griffith J
    Clin Infect Dis; 1997 May; 24(5):824-9. PubMed ID: 9142776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective study of cytomegalovirus infection in liver transplant recipients].
    Lumbreras C; Otero JR; Aguado JM; Lizasoaín M; Gómez R; García I; Fuertes A; Colina F; Moreno E; Noriega AR
    Med Clin (Barc); 1992 Oct; 99(11):401-5. PubMed ID: 1335102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.